enews
International Federation of Clinical Chemistry
and Laboratory Medicine

Communications and Publications Division (CPD) of the IFCC
Editor: Katherina Psarra, MSc, PhD
IFCC Office, Via C. Farini, 81
20159 Milano, Italy
E-mail: enews@ifcc.org

news

№9
September 2023

1

enewsIn this issue
Editorial
Message from the eNews Editor

3

The voice of IFCC
Message from the IFCC President

4

My Professional Scientific Exchange Programme at Biochemical Genetics

6

Laboratory, Department of Laboratory Medicine and Pathology, Mayo Clinic(Rochester, Minnesota, United States of America).
My experience with the IFCC Professional Scientific Exchange Program at Fares

9

Taie Laboratory in Mar del Plata, Argentina
The IFCC - Abbott Visiting Lecturer Programme at 8th Annual Academic

12

Sessions 14th and 15th July 2023 - Grand Kandyan Hotel, Kandy, Sri Lanka
TF-OSLM call for study

15

ETD Toolkit for emerging technologies in laboratory medicine

17

IFCC: the people
Call for nominations

19

Contribute to IFCC eNews
Improving the Peri-Operative Pathway of People with Diabetes Undergoing

20

Elective Surgery: The IP3D Project
Program ROSE (Removing Obstacles to cervical ScrEening) - empowering women23

to eliminate cervical cancer
Safe and Informed Population Health Management: The National Basketball

26

Associations COVID-19 Bubble

News from Regional Federations and Member Societies
Updates in Thyroid Hormone Testing

29

AACC Has Become ADLM

30

IFCC’s Calendar of Congresses, Conferences & Events
IFCC and Regional Federations events

33

Corporate Member events with IFCC auspices

34

Other events with IFCC auspices

34

2Editorial
Dear colleagues
I hope you have really enjoyed your holidays, and came back full ofenergy. This summer was difficult for a lot of people worldwide due tothe high temperatures, the fires, the extreme climatic phenomena.
Nevertheless, the beautiful holidays memories will keep us company
during the months at work lying ahead.
In this relatively small eNews issue you will read about sensational
events in the IFCC family, that took place during the summer, as they
are described by our President, Prof Khosrow Adeli, who invites all of
us to a productive IFCC fall.
Two descriptions of the experiences with the IFCC Scientific Exchange
Program make us realize the importance of this program. It permits ourcolleagues to live in a foreign country, to participate in the life of animportant lab, to acquire and share knowledge with other colleagues,
to bring this knowledge to one’s own lab, to make friends and be
inspired. Read these reports and get prepared to apply for such a
program. You will see that it may change your professional life and it
will help your lab as well.

Katherina Psarra, MSc,
PhD, eNews Editor

In this issue you can also read about the 8th annual meeting of ourcolleagues in Sri Lanka, made more interesting and more successful
with the participation of Prof Ken Sikaris and Prof Tony Badrick,through the VLP program, another important IFCC program that all
IFCC national societies can apply for.
Three scientific groups, winners of the UNIVANTS rewards, arepresented in this issue, all of them very interesting. I am sure the NBA
COVID-19 bubble will catch your attention. Are we talking about “TheNBA”? Well yes go ahead, read and find out why an article about NBA
finds its place in the IFCC eNews.
Don’t forget, dear colleagues, that opinions from all over the world
are heard in the eNews. We are looking forward to listening to yourparticular and beautiful voice.
Enjoy the last summer days and the beginning of autumn with thecompany of IFCC eNews.

Katherina

3

The voice of IFCC
IFCC President’s Message
September 2023
By Khosrow Adeli

Greetings to everyone in the IFCC family! I hope you have all had awonderful summer. The IFCC Executive Board is looking forward to a very
productive Fall season in collaboration with all IFCC functional groups andaffiliated organizations.
There were several important events held this summer by IFCC nationalsocieties. Among these events one holds special significance: the 60th
anniversary celebrations held by the Vietnamese Society of Clinical
Biochemistry (VACB)—a truly remarkable accomplishment. I had theprivilege of representing IFCC during this exceptional event in Hanoi andoffering support to VACB as they celebrated this significant milestone.
VACB was formed in 1963 even amid the challenging backdrop of theVietnam War!
Another major event held this summer was the AACC conferencein Anaheim during which AACC formally changed its name to ADLM
(Association for Diagnostics and Laboratory Medicine). The new namebroadens the Association’s scope to encompass several other domains
within laboratory medicine and is hoped to expand membership andenhance visibility of the organization in the eye of the public and otherstakeholders. During the conference in Anaheim, the IFCC Executive
Board met with the AACC/ADLM Executive Board and exchanged ideas
on ways to expand collaboration between our two organizations. Several
areas were identified where we have common interests and activities andit was agreed to join forces so that we minimize duplication and enhance
productivity on various international projects in areas such as newborn
screening, global lab quality, as well as educational programs.

Prof. Khosrow Adeli
PhD, FCACB, DABCC,FAACC

The IFCC Executive Board also met separately during the Anaheim
conference and discussed many other IFCC priorities including IFCC
clinical laboratory practice guidelines, conference organizational matters,
and accreditation of future WorldLab Congresses. The Executive
Board has formally approved the formation of a new Working Group on
Continuing Education/Accreditation to begin planning accreditation of
the Dubai WorldLab 2024 scientific program as well as other future IFCC
events in collaboration with the CPECS program developed by EFLM.
Progress is also being made on development of the new IFCC ClinicalLaboratory Practice Guidelines. The program is aimed at development
and dissemination of best practice recommendations/guidelines in allareas of clinical laboratory medicine and facilitating implementationin clinical laboratories worldwide, particularly in developing countries.
Under this program, IFCC functional units will be encouraged to employ
their expertise to develop one or more of the following documents: bestpractice recommendations, clinical laboratory consensus statements

Article continued on the next page

4

IFCC President’s
Messageor position papers based on evidence from wide range of existing
reputable guidelines, peer-reviewed publications, and expert consensus
as well as clinical laboratory practice guidelines (CLPG) (evidencebased using a grade system using a standardized methodology for
producing guidelines). Stay tuned! a formal announcement will be madeover the coming weeks and all IFCC functional units will be invited toparticipate and submit proposals for development of such best practicerecommendations and guideline documents.
Looking forward to a very productive fall season for IFCC member
societies, national federations, and colleagues from around the world. As
always, feel free to email me at president@ifcc.org with your feedback,questions, or concerns.
Cheers,Khosrow

5

My Professional Scientific Exchange Programme (PSEP)
at Biochemical Genetics Laboratory, Department ofLaboratory Medicine and Pathology, Mayo Clinic (Rochester,
Minnesota, United States of America).
By Mariana Serres Gómez, Resident of Laboratory Medicine in La Paz University Hospital, Madrid, Spain

Supervisor: Dr. Matern
Topic: Inborn errors of metabolism
My name is Mariana Serres Gómez. I studied a double bachelor’s degree in Chemistry andBiochemistry and I am currently in my third year of residency program in Laboratory Medicine in La
Paz University Hospital (Madrid, Spain). The residency program in Spain lasts 4 years, and during
this period we have three months where we can do an external rotation in a hosting laboratory to
expand our knowledge in a specific discipline of Laboratory Medicine. I have always had a special
interest in metabolism since I studied my bachelor’s degree and discovered this incredible subject.
During my residency program, I had a short rotation in the Inborn Errors of Metabolism Laboratoryof my hospital. It reconfirmed my passion in this topic and led me to apply for an external rotation tobroaden my knowledge and specialize more in this field. I was very fortunate to be able to contact
Dr. Dietrich Matern from the Biochemical Genetics Laboratory (BGL) at Mayo Clinic. BGL performs theevaluation and diagnosis of patients and families with inherited metabolic diseases. The laboratory
staff routinely performs qualitative detection and quantitative determination of diagnostic markers
based on a variety of manual, automated and chromatographic methods including high performanceliquid chromatography (HPLC), gas chromatography-mass spectrometry (GC-MS) and tandem mass
spectrometry (MS/MS).
The main summarized objectives from the PSEP program were:•
Gain expertise in laboratory techniques used in the diagnosis of inborn errors of metabolism.
•

Expand and deepen the knowledge of inborn errors of intermediary metabolism, focusing on
results interpretation for the correct diagnosis and follow-up of these patients during monitoringof treatment.

•

Learn about lysosomal and peroxisomal storage disorders.

•Experience the process of development of new methods and research in new second-tierbiomarkers.

During my stay, I participated in various tasks, and I was able to learn more about the operation of areference laboratory such as BGL in the USA. Most of the mornings I did observation rotating in thelaboratory stations to learn the different techniques, from sample preparation to the final obtainingof results and chromatograms for interpretation. I was able to see techniques such as FIA-MS/MS,
LC-MS/MS, GC-MS, MALDI-TOF, QTOF and enzymatic assays. Also, I had the opportunity to learn theprocessing of blood spot samples as BGL participates in some newborn screening programs.
Every afternoon I participated in a meeting with the Consultant and Fellow “on call” for chromatogramand profile interpretation, assignment of comments and signing of results. This was an incredible
experience for me, being able to be present in this process was an excellent way of learning. I was
also able to attend seminars presented by the Fellows and Consultants on clinical cases, literature

Article continued on the next page6

My Professional ScientificExchange Programme

reviews and sessions on specific topics with the latest updates.
In addition, I learned how to use at a basic level CLIR (Collaborative Laboratory Integrated Reports)
program, which is a post-analytical web tool with an interactive laboratory database contributedby multiple centers internationally, and it is primarily used for interpretation of newborn screening
results.
At the research level, I feel very grateful to have had the chance to prepare a case report of Gaucher
disease together with Dr. Matern that allowed us to submit an abstract to a congress. On the other
hand, Dr. Patricia Hall and Dr. Silvia Tortorelli, proposed me to study different biomarkers from womenwith Fabry disease and I was able to prepare another communication. These two works allowed
me to deepen my knowledge on the group of lysosomal disorders, which are not studied in thelaboratory of my hospital.
This experience has undoubtedly been a valuable contribution to my professional future. I got toknow closely the way of working, organization and structure of a world reference laboratory fromwhich I have learned a lot. I have had the opportunity to spend 3 months in a foreign country,
speaking another language and interacting with people from different countries and professional
backgrounds. I have attended meetings with Consultants and Fellows that have helped me to gain
more self-confidence, to discuss cases with them and to become more fluent in the interpretation ofchromatograms and complex cases.
An external rotation abroad is a great learning opportunity both personally and professionally. I feelvery fortunate to have been able to live this enriching experience. I would definitely recommend
doing an external rotation to other residents.
I would like to thank the International Federation of Clinical Chemistry (IFCC) for giving me theopportunity to carry out this external rotation through the support of the Professional ScientificExchange Programme (PSEP) scholarship. I would also like to extend my gratitude to the BGL team,
the Consultants, Fellows and Amy Piazza (the Education Specialist), for always being willing to solve
doubts, comment on cases and for their help and support during my stay, but specially to Dr. Matern
who made this stay possible, who trusted me and encouraged me to work on a clinical case. Finally,
I would like to thank Dr. Antonio Buño Soto, head of the Department of Laboratory Medicine from my
hospital, for helping me in the application process and showing his support during the whole stay.

Article continued on the next page7

My Professional ScientificExchange Programme

In this photo I am with the PhD student Rachel Wurth and theIn this photo we are outside the Mayo Building

Fellow Dr. Zinandré Stander from BGL.

In this photo I am sitting next to the statues of the Mayo

With Amy Piazza, the Education Specialist who supervised

brothers, founders of Mayo Clinic.

my rotation program during my stay at BGL.

8

My experience with the IFCC Professional ScientificExchange Program at Fares Taie Laboratory in Mar del Plata,
Argentina
By Fernanda Larrambebere
Clinical Biochemist
Paysandú, Uruguay

My name is Fernanda Larrambebere, I am a Clinical Biochemist from Paysandú, Uruguay. At the
beginning of 2023, I had the incredible opportunity to participate in the IFCC Professional ScientificExchange Programme (PSEP) at Fares Taie Laboratory in Mar del Plata, Argentina, under thesupervision of Dr. Santiago Fares Taie.
In 2019 after five years working as a Clinical Biochemist in Uruguay, I realized Endocrinology
Laboratory was still emerging in my country, with very few professionals specialized in this area.
Being aware of the growing demand for endocrinology tests and the complexity involved in theirinterpretation, I decided to further my education in this field by starting my postgraduate studies atUniversidad de Buenos Aires in Argentina. This year, the IFCC PSEP provided me with an opportunity
to do a 3-month training at Fares Taie, which complemented and allowed me to complete my studies.
Fares Taie Laboratory has a team of highly qualified and dedicated professionals and is equippedwith the latest technology and work algorithms based on vast experience. The Endocrinology
section is led by Dr. Santiago Fares Taie and receives high daily workloads. From the first day I was
received with enthusiasm and willingness to share their expertise.
Working alongside Santiago allowed me to carry out intensive training and study diverse clinicalcases that helped me strengthen the interpretation of laboratory results. He shared his knowledge
making sure that I gained a comprehensive understanding of the intricacies of endocrinology. I
was guided through each step of laboratory protocols, with special emphasis in the importanceof precision and accuracy in hormone measurements, utilizing sophisticated methods such as
immunoassays and mass spectrometry.
During my training period, I devoted a significant amount of time to scientific research based on upto-date bibliography, followed by collaborative discussions with Santiago. This opportunity allowed
me to thoroughly examine each of the topics related to endocrinology, expanding my knowledge inthe field. In addition, daily validation of results with the specialist, contributed to strengthening mycriteria for the interpretation of results.
Also, I had the opportunity to attend conferences on various relevant topics around endocrinology,
which enriched my understanding and kept me updated on the most recent advances andchallenges in the field. Many of the techniques and algorithms that I learned during my training are
currently being implemented in the laboratory where I work. This reflects how my training experience
not only benefited me on a personal level but has also had a direct impact on my professional
performance and the quality of the studies carried out in my workplace.
An additional significant aspect of my training was the opportunity to develop my final thesis, basedon an atypical case of Addison’s Disease. Throughout this process, I had the privilege of interviewing
the patient, seeking specialist opinions, and having access to all laboratory studies conducted forthe diagnosis and follow-up.

Article continued on the next page9

My experience with the IFCC
PSEP at Fares Taie Laboratory

My main focus was on the endocrine section, but I also interacted with professionals working inother sections such as hematology, immunology, and molecular biology. I participated in seminars,
familiarized myself with other laboratory equipment, and exchanged ideas for daily work. I gained
a more comprehensive perspective on the diagnostic and research capabilities of the laboratory,
realizing the importance of a multidisciplinary approach in unraveling the complexities of endocrine
disorders. Additionally, I acquired knowledge in analyzing quality control data based on the Six Sigma
methodology. This valuable tool is now being implemented in my current workplace as well.
Participating in the Professional Exchange Program was an extraordinary experience that broadened
my perspective, enriched my skill set, and fostered lasting connections with other professionals. I am
profoundly grateful to the IFCC and to Fares Taie Laboratory for the opportunity to be part of thisprogram.
I strongly encourage other professionals to seize a PEP experience, for their personal andprofessional development. The lessons and connections I gained will undoubtedly influence mycareer positively for years to come.
Finally, I would like to express my gratitude to Dr. Santiago Fares Taie and Belén Uñates fortheir unwavering support, guidance, and dedication throughout my time in the laboratory. Theirwarm hospitality made my experience in Mar del Plata feel like home. I am truly grateful for theircontributions to my training and for creating an enriching and welcoming environment.

Mar del Plata view(L-R) Santiago Fares Taie, Dr. Fernanda Larrambebere, andLaboratory Technician Belén Uñates

Fares Tale Laboratory staff in Mar del Plata

10

11

The IFCC - Abbott Visiting Lecturer Programme at 8th
Annual Academic Sessions 14th and 15th July 2023 - Grand
Kandyan Hotel, Kandy, Sri Lanka
By Dr Dinesha Maduri Vidanapathirana
Senior Lecturer/Consultant Chemical Pathologist/Joint Secretary of the College of Chemical Pathologist of
Sri Lanka/Corresponding member of IFCCDepartment of Pathology, Faculty of Medical Sciences Universityof Sri Jayewardenepura - Sri Lanka

This report aims to provide a concise overview of the College of Chemical Pathologists of Sri Lanka’s
experience with the IFCC - Abbott Visiting Lecturer Programme (VLP). The report highlights thecollege gratitude for the program support in providing two eminent speakers for their 8th Annual
Academic Sessions, held on 14th and 15th July 2023 at Grand Kandyan Hotel, Kandy, Sri Lanka. It
acknowledges the successful conference, the positive reception of the lectures delivered by ProfKen Sikaris and Prof Tony Badrick, the problem-solving achievements, networking opportunities, andthe hope for continued support from the IFCC VLP in the future.
The College of Chemical Pathologists of Sri Lanka expresses deep gratitude to the IFCC Abbott
Visiting Lecturer Program for their support in providing two eminent speakers for their Annual
Academic Sessions. Despite the adverse economic situation Sri Lanka is currently facing, the college
is extremely grateful for the opportunity to collaborate with such renowned experts.
The conference organized by the college was a resounding success, attracting a wide range ofprofessionals in the field of Chemical Pathology. There were 75 participants in the main academic
program and 233 participants in the Medical Laboratory Science program.
The lectures delivered by Prof Ken Sikaris and Prof Tony Badrick were exceptionally well received
by the attendees. Their expertise, knowledge, and engaging presentation styles made a significant
impact on the participants, providing them with valuable insights into the latest advancements inthe field.
The VLP facilitated meaningful discussions and problem-solving sessions, allowing participants toaddress various challenges faced in the field of chemical pathology. Through interactive exchanges
and collaborative efforts, participants were able to find practical solutions to the problems theyencountered. The VLP played a vital role in fostering a collaborative environment that facilitated thesharing of experiences and expertise among professionals.
Also, the VLP provided an excellent platform for networking and establishing connections among
the professionals in the field of chemical pathology. Participants had the opportunity to meet andengage with colleagues from different institutions and backgrounds. These networking interactions
allowed for the exchange of ideas, best practices, and potential collaborations. The opportunity
to build such connections was invaluable for enhancing professional growth and fostering future
partnerships.
The College of Chemical Pathologists of Sri Lanka expresses its sincere hope for continued support
from the IFCC Abbott Visiting Lecturer Programme in the future. The collaboration with IFCC VLP has
been instrumental in the success of the annual sessions, and the college believes that further

Article continued on the next page

12

The IFCC - Abbott Visiting
Lecturer Programme, Sri Lanka

support would strengthen its ability to provide high-quality education and professional development
opportunities in the field of Chemical Pathology. The college is eager to continue working with the
IFCC VLP to promote excellence and advancement in the field.

Speakers on stage: (L-R) Dr Ken Sikaris, Dr Tony Badrick, Dr(L-R) L-R Dr Manjula Dissanayake, Consultant Chemical

Pradeep Datta, Prof. Praveen Sharma.

Pathologist/Past President of the College of Chemical
Pathologists of Sri Lanka (CCPSL) 2020, Prof Tony Badrick,CEO of the Royal College of Pathologists of Australasia
Quality Assurance Programs, Australia, Dr B.K.T.P
Dayanath, Consultant Chemical Pathologist/Past President of
CCPSL 2018, Colombo North Teaching Hospital, Ragama, Sri
Lanka

Speaker, VLP Speakers and Organizing committee members of the 8th Annual Academic Sessions which was held on 14th and15th July 2023 at Grand Kandyan Hotel, Kandy, Sri Lanka with IFCC President, prof Adeli.

13

Satellite Meeting

SATURDAY

25TH
MAY
2024
INTERNATIONAL CONGRESS
OF PEDIATRIC LABORATORYMEDICINE
TopicsImmunodeficiencies
Immuno-flow cytometry in pediatriclaboratory medicine
Genomics vs Mass spectrometry
in pediatric laboratory medicine
Newborn Screening for SCIDs
NGS in diagnosing
undiagnosed diseases

Organizing Secretariat
Phone: +39 02 66802323
info@dubai2024.org

14

Task Force on Outcome Studies in Laboratory Medicine (TFOSLM) Call For Outcome Study Proposals 2023
Research Funding Available

Call For Outcome Study Proposals 2023
Extended Deadline
IFCC’s Task Force on Outcome Studies in Laboratory Medicine (TF-OSLM) is seeking research
proposals for studies evaluating the impact of laboratory testing on healthcare outcomes.
Study proposals should seek to evaluate the clinical effectiveness and impact of new and/or
commonly available medical laboratory tests and/or laboratory information on patient care outcomesin clinical practice. It is crucial for the proposed study to link the laboratory testing insights to patientmanagement, and improvements/changes in clinical outcomes. If you, in collaboration with yourclinical colleagues, are interested in applying please click here for full eligibility criteria and details on
how to apply.
All applications are due by: October 1, 2023
Don’t Miss Your Chance to Demonstrate the Value of Laboratory Medicine!!

IFCC Annual Report 2022
The IFCC Annual Report 2022, compiled by Dr. David Kinniburgh, IFCC
Secretary, is now available. Read the Message from the President anddiscover the many IFCC activities towards its mission: “Advancing excellencein laboratory medicine for better healthcare worldwide”.
In the IFCC Annual report 2022, you will find reports from IFCC Officers
on key projects covering a wide range of clinical, scientific, educational,
and communication-related topics. National or Area Societies andRegional Federation reports are also included, allowing the opportunity tocommunicate their activities to other members.
Click on the image to download your copy!
News from the website

15

Free Educational Webinar

Topic

Troubleshooting with
Quality Control Data
in Medical Laboratories
for Beginners

26th September

2pm BST, 3pm CEST and 9am EST
Delivered by:

Oswald Sonntag

Independent Consultant

During this webinar, Oswald will explain how to identify problems anderrors that occur during the analytical phase in the medical laboratory.

REGISTER NOW

16

ETD Toolkit for emerging technologies in laboratory
medicine
CCLM article by the IFCC Emerging Technologies Division (ETD)

An emerging technology (ET) for laboratory medicine canbe defined as an analytical method (including biomarkers)
or device (software, applications, and algorithms) that by its
stage of development, translation into broad routine clinicalpractice, or geographical adoption and implementation has thepotential to add value to clinical diagnostics. Considering thelaboratory medicine-specific definition, this document examines
eight key tools, encompassing clinical, analytical, operational,
and financial aspects, used throughout the life cycle of ET
implementation. Whilst there are differences in clinicalpriorities between different settings, the use of this set oftools will help support the overall quality and sustainabilityof the emerging technology implementation.
Click here to read the article

17

www.dubai2024.org

26th International Congress ofClinical Chemistry and Laboratory Medicine
17th Congress of Arab Federationof Clinical Biology
10th Saudi Society for Clinical
Chemistry Annual Meeting
8th International and UAE Genetic
Disorders Conference

DEADLINES
15 January 2024
Deadline for poster abstract submission

Dubai World
Trade Centre (DWTC)

15 March 2024
Deadline for reduced registration fees
18

IFCC: the people
IFCC Calls for Nominations
Communications and Publications Division (CPD) Call for nominations•
Committee on Public Relations (C-PR) - 2 members positions•
Working Group eJIFCC – eJIFCC Editor-in-Chief position•
CPD-Executive Committee (CPD-EC) Corporate Representative position
Nominations should be sent to the IFCC office (colli-lanzi@ifcc.org) by 31st October 2023
Task Force Corporate Members (TF-CM) Call for nominations 3 Member positions
Nominations should be sent to the IFCC office (paola.bramati@ifcc.org) by 31st October 2023
For any further information on nominations, please refer to your National or Corporate
Representative - contacts are available here.

“Challenges of digital technologies and artificial intelligence in laboratory medicine”
On-demand content now available! Click here to access the recorded webinar

The IFCC webinar: “Challenges of digital technologies and artificial intelligence in laboratory
medicine” was held on July 27, 2023.
The digital revolution does not stop at any area of life and also plays a major role in healthcare. The
young professional and researcher in laboratory medicine, or Young Scientist, has a key role in thischanging lab environment and tries to seize new opportunities given by technological evolutions.
This webinar covered challenges of digital technologies in laboratory medicine from several facets,
including digital competences, artificial intelligence, and applications of bioinformatics in clinicalroutine.
This webinar comprises of three following presentations of 20 min each followed by 20 min of panel
discussion at the end.
Moderators: Dr. Marie Lenski and Dr. Ashlin Rampul
Talk 1 - “Skills of the Future - What kind of digital competence is needed?” Dr. Jakob Adler
Talk 2 - “Augmenting Intelligence: Basics of Artificial Intelligence in the lab” Dr. Reinhardt Hesse
Talk 3 - “Bioinformatic infrastructure, pipelines, and impact in clinics” Dr. Augustin Boudry
Certificate of participation: available for all registrants
News from the website

19

Contribute to IFCC eNews
Improving the Peri-Operative Pathway of People with
Diabetes Undergoing Elective Surgery: The IP3D Project
In a world where patient empowerment can improve outcomes, enhance experiences and save costs,
integrated clinical care strategies that focus on patient engagement are an impactful first step. Thatsaid, it is never as easy as it sounds, particularly for patients with complex diseases. Perioperative
pathways, in particular, can be challenging for patients with diabetes, as many patients experienceanxiety and dissatisfaction with their care. Beyond the patient experience, patients with diabetes
are more likely to experience post-operative complications, have higher rates of mortality and tend tohave longer lengths of stay with more frequent readmissions.
Despite numerous guidelines in this space, little improvements have been seen for patients withdiabetes who are undergoing surgery. Recognizing that more had to be done, Professor Gerry
Rayman, Consultant Diabetologist, Ipswich Hospital, East Suffolk and North Essex NHS Foundation
Trust and Emma Page, Transformation Manager and Project Lead developed and implemented theIP3D program: Improving the peri-operative pathway of people with diabetes undergoing elective
surgery. IP3D involves several critical success factors, including a ‘diabetes perioperative passport’ tohelp empower patients throughout their surgical processes, formation of a diabetes-surgery working
group, recruitment of surgical diabetes champions and recruitment of a Perioperative Diabetes
Specialist Nurse (DSN). The DSN is responsible for engaging and educating others involved in thepathway and supporting patients with their diabetes care pre-surgery and on admission, including
optimization of HbA1c.
The results of the IP3D initiative have been astounding. There was a 12% (from 28% to 16%; P=0.008)
reduction in in-hospital complication, including a decrease in those who experienced a composite
of dysglycaemic complications, poor wound healing, wound infection, and other infections (12.4%
vs 5.4%; P=0.023), as well as reductions in dysglycaemic events such as recurrent hypo andhyperglycemia. A corresponding 1.5 day (from 4.8 to 3.3 days p=0.001) reduction in patient lengthof stay was also achieved for patients with diabetes, without a significant increase in 30-day
readmission. Collectively, these impressive achievements mitigate £157,000 per year (525 hospital
bed-days).
Due to the meaningful improvements in outcomes and patient care, the IP3D program has since
been implemented into >10 different NHS Trusts, all with similar, outstanding results.
The outcomes achieved and improvements seen would not be possible without the passionate teambehind IP3D. For their efforts, this integrated clinical care team was a awarded the Top Global Honorof 2022 UNIVANTS of Healthcare Excellence Award Winner.

Article continued on the next page

20

The IP3D Project(L-R) Rachel Allen, Ruth Deroy, Gerry Rayman, Emma Page,
Alison Czarnota

Congratulations to Professor Gerry Rayman, Consultant Diabetologist, Ipswich Hospital, East
Suffolk and North Essex NHS Foundation Trust, Emma Page, Transformation Manager and ProjectLead, Rachel Allen, Lead Perioperative Diabetes Specialist Nurse, Ruth Deroy, Lead Consultant for
Perioperative Care and Alison Czarnota, Point of Care Lead Ipswich Hospital.
To learn more about IP3D and other winners please visit www.UnivantsHCE.com
For educational opportunities, including an inspiring lecture on the IP3D program, please visit
https://healthcareelx.com/

21

REGISTER TODAY for this Healthcare Excellence Educational Forum“If we as organizations
want to call ourselves
healthcare organizations,
we have to be involved
in more than just thedelivery of medical careafter someone gets sick.”
MICHAEL DOWLING
President and CEO,
Northwell Health, USA“Every voice matters
as we collaborate
to improve thehealth of individuals
and populations
around the world.”
CHRISTINA CARABALLO
Vice President, Informatics,
HIMSS, USA“Sometimes things are notin the budget but sometimes
we have to figure out
how to do it, particularly
if it is going to make a huge
difference for patients.”
QUINT STUDER
Co-Founder, Healthcare Plus
Solutions Group, USA“We have to completely
reimagine what is the role ofthe clinical lab, not at a test level,but in the longitudinal wayof data that gives us a meaningful
way to predict risk.”
KHOSROW SHOTORBANI
President, Executive Director,
Project Santa Fe Foundation, USA
Founder and CEO,Lab 2.0 Strategic Services, USA“We have opportunities todevelop appropriate clinicalalgorithms that can help ensurethat patients get the carethat they need”
OCTAVIA PECK-PALMERDivision Director, Clinical Chemistry,
Associate Professor of Pathology,
University of Pittsburgh
School of Medicine, USA“Together, we can address
diagnostic error which
the NASEM reports
to not only be possible,
but a moral, professional,
and public health imperative.”
PAUL EPNER
Vice-Chair,
Sepsis Alliance, USA“Many of us have theideas, the plans and thescientific knowledge,
but we need to be able
to ensure that it aligns
with what people areable to do.”
YIN LING WOO
Professor of Obstetrics
and Gynaecology, Consultant
Gynaecological Oncologist,
University of Malaya,
University Malaya
Medical Centre, Malaysia“Through the use of a new
biomarker, multiple healthsystems were able tosave and mitigate
downstream costs while
improving health forthe entire ecosystem.”
TRICIA RAVALICO
Director, Scientific Leadershipand Education, Core Diagnostics,
Abbott, USA

Executive Leadership Exchange
October 3 – 4, 2023
Open to all healthcare professionals.
Learn more at www.healthcareELX.com
ADD-145976-GBL-EN

22

Program ROSE (Removing Obstacles to cervical ScrEening)- empowering women to eliminate cervical cancer
Mother. Sister. Wife. Friend. Colleague. Daughter. We can all appreciate the importance of the womenin our lives. We can further appreciate the importance of doing everything we can to protect theirhealth and wellness. One such area that requires direct attention is screening and prevention of
cervical cancer.
Screening for cervical cancer is typically done through Pap Smear, with subsequent analysis ofcollected cells for cellular changes indicative of cancer. Pap smears can be often uncomfortable,
painful and/or inconvenient, such that many women do not receive the optimal cadence for screening.
In Malaysia, this is no different, where only 1 in 4 women receive regular Pap Smears. Compounding
this issue is that results are often delayed for more than 3 months and many not linked to care.
Program ROSE (Removing Obstacles to cervical ScrEening) sought to shift the standard of care for
cervical cancer screening to a self-swab method for Human Papillomavirus (HPV) screening, as 99%
of cervical cancers are caused by high-risk HPV. This swab methodology not only identifies high-risk
HPV strains but empowers women in a culturally sensitive way and requires less frequent follow-up,
with improved diagnostic accuracy.
By combining self-swab collection with digital follow-up technology, Program ROSE has been able toprovide improved access to high quality, while preserving the privacy and dignity of these women.
To date, >22,000 women have been screening through Program ROSE (from 2018-Feb 2023). Of them
5.6% have screened positive for HPV, with 91% of those women being linked to care. Importantly, 4cases of previously unidentified, early-stage cancers and 194 women with precancers were identified
and linked to the appropriate care.
Program ROSE has also helped to tackle the stigma associated with HPV testing, which in turn has
further helped to increase screening efforts. Iffah Amin, Staff Nurse at University Malaya Medical
Centre, shares that “many patients think that HPV is STD. They feel shameful about it, and somewill even blame their partners for having extramarital affairs. Proper messaging and education isfoundational for Program ROSE to help everyone understand that HPV is common and that testing
positive does not mean they have done anything wrong. It’s a great start to normalizing HPV testing.”

Article continued on the next page23

Program ROSE

(L-R) Yit Lee Choo, Mun Li Yam, Marion Saville, Yin Ling Woo,
Adeeba Kamarulzaman

The positive impact that Program has had and will continue to have on the health and wellnessof Malaysian women will be felt for generations to come. For their efforts and outcomes, Program
ROSE has been awarded the Top Global Honor of 2022 UNIVANTS of Healthcare Excellence Awards
Winning Team. Congratulations to Yin Ling Woo, Founding Trustee and Medical Technical Advisor,
ROSE Foundation Marion Saville, Professor of Laboratory Medicine and Trustee for the ROSE
Foundation, Yit Lee Choo, CEO, ROSE Foundation, Adeeba Kamarulzaman, Chair, ROSE Foundation,
Mun Li Yam, Operations Director, ROSE Foundation.
To learn more about program ROSE and other winners please visit www.UnivantsHCE.com
For educational opportunities, please visit https://healthcareelx.com/

24

REGISTER TODAY for this Healthcare Excellence Educational Forum“Equitable access to careacross populations andgeographies is a global
health imperative.”“It is important toremember that we aren’t
treating diseases.
We are treating
patients, and thatis precision medicine.”“Innovation thrives when you
celebrate the power of crossorganizational teamwork.”
AMY PERRY
President and Chief Operating Officer,
Banner Health, USA

KETUL J. PATEL
Chief Executive Officer Virginia
Mason Franciscan Health &Division President,
Pacific Northwest,
CommonSpirit Health, USA

KUN RU
Chair of Departmentof Pathology and Lab Medicine,
Shandong Cancer Hospital, China“Laboratory data
can be harnessed
to demonstrate
the laboratory’strue value.”“In healthcare, we talkso much about the voiceof the patient. In the case of
the NBA Bubble, it was morevoice of the population.”“With the tools we have
today and if we can deliver themfairly and equitably, we caneliminate cervical cancer
as a public health problem.”

DAVID GRENACHE
Chief Scientific Officer,
TriCore Reference
Laboratories, USA

CHRISTINA MACK
Chief Scientific Officer,
IQVIA Real World Solutions, USA

MARION SAVILLE
Executive Director,
Australian Centre for thePrevention of Cervical Cancer,
Australia“Look at yourenvironment,
get your culture right,
get your purpose right,
and eventually
success happens.”
RORY MCCRIMMON
Dean of Medicine,
Univeristy of Dundee,
Scotland“Our goal is to improve
quality and safety
through the single
biggest lever available
to healthcare leaders.”
TED DONNELLY
Vice President, Client Success,National Association for
Healthcare Quality, USA

Executive Leadership Exchange
October 3 – 4, 2023
Open to all healthcare professionals.
Learn more at www.healthcareELX.com
ADD-145977-GBL-EN

25

Safe and Informed Population Health Management: The
National Basketball Associations COVID-19 Bubble“Talent wins games, but teamwork and intelligence win championships” – words spoken by Michael
Jordan himself. These words take on new meaning in context of the 2020 National Basketball
Association’s (NBA) finals.
Three components of Michael Jordan’s quote resonate when thinking about the 2020 NBA finals andmore specifically, the NBA Bubble; Teamwork. Intelligence. Champions.
The COVID-19 pandemic impacted all non-essential industries including the shutdown of the2020 NBA season. Soon after, the NBA and its partners sought to find a way to not only restart
the basketball season, but to do so safely and as informed as they could. Thus, the NBA Bubble
was conceived. The teamwork required from inception to implementation of the NBA Bubble
is unparalleled. This closed campus, occupational health program that operated between July
2020 to October 2020 required collaborations in ways not seen before. NBA players worked withepidemiologists, working with Laboratorians, working with virologists and immunologists and more.
Teamwork enabled the NBA to safely conclude its season and help bring a sense of normalcy to the
public during difficult times.
Another critical success factor of the Bubble involved meticulous and fastidious use of data and data
insights. Daily SARS-CoV-2 testing, symptom monitoring and input from the evolving medical fieldenabled not only buy in for the Bubble but enable constant updating and morphing of safety policies
and procedures. Further, the evolving insights developed from the NBA Bubble were published in
more than 8 peer-reviewed journals, with these contributions to the medical and scientific literature
helping to guide public health measures in the US and around the globe.
The NBA Bubble was a novel and bold approach to utilize laboratory medicine to facilitate operationof a global sports league, and their innovation paid off. Through strong collaborations, unwavering
use of data, the NBA finals concluded with no COVID-19 cases among players and team staff. The
program created more than 6,500 jobs and bolstered the Orlando economy by more than $200M.
The data collected in the Bubble and shared through scientific publications served to advance themedical field in a time when uncertainty was the only certainty and gave a sense of hope in a time
when things may have felt hopeless. An integrated clinical care team associated with the NBA
Bubble was recently awarded the Top Global Honor of 2022 UNIVANTS of Healthcare ExcellenceAwards Winning Team.

Article continued on the next page

26

The NBA COVID-19 Bubble(L-R) Dave Weiss, Jim Weisberger, Christina Mack, Yonatan
Grad, David Ho

Congratulations to Christina Mack, Chief Scientific Officer, IQVIA, Real World Solutions, Dave Weiss,
Vice President, Player matters, NBA, Jim Weisberger, Chief Medical Officer, BioReference Labs,
Yonatan Grad, Associate Professor of Immunology and Infectious Disease, Yale University, David Ho,
Professor Medicine and Microbiology & Immunology, Columbia University.
To learn more about the NBA Bubble and other winners please visit www.UnivantsHCE.com
For educational opportunities, including a wonderful presentation on the NBA Bubble, please visit
https://healthcareelx.com/

27

CALLING ALL HEALTHCAREPROFESSIONALS
Register for ELX today for access to educational presentations
from >30 faculty, covering relevant and thought-provoking topics.

A representative standout session:

Evolving from transactional to outcome
focused care through strategic collaborations

PAUL EPNER

Healthcare Strategist

DAVID GRENACHE
Chief Scientific Officer,
TriCore Reference LabsJOHN SPROULE

Senior Policy Advisor,
Institute of Health Economics

Full program details
and registration accessat www.healthcareELX.com

DON’T MISS OUT
on this Premier Educational Event
ADD-145978-GBL-EN

28

News from Regional Federations and Member
Societies

Updates in Thyroid Hormone Testing
By Dr. Fatima Kanani
Indus Hospital and Health Network, Karachi, Pakistan

A Continuous Medical Education (CME) activity was held in Indus Hospital and Health Network(IHHN), Karachi Campus on Updates in Thyroid Hormone Testing under the auspices of IFCC and incollaboration with Pakistan Society of Chemical Pathology (PSCP). The activity was accredited for two
CME hours by PSCP. The session was hybrid, and was well attended by over 70 participants virtuallyand physically. The session started with a brief introduction to the topic and a pre-test conducted by
Dr. Fatima Kanani. This was then followed by talks from the esteemed speakers. Dr. Adnan Mustafa
Zubairi presented a comprehensive talk on “Using Diagnostic Tools Effectively in Thyroid Disease”,
covering biochemical as well as imaging techniques. He discussed testing algorithms and ways
to cost-effective test utilization. This was followed by a presentation from Dr. Mohammad Zubair,Consultant Chemical Pathologist from Multan Institute of Kidney Diseases (MIKD) Campus of IHHN. He
spoke on “Diagnostic Methods of TSH in Thyroid Screening Tests”. Dr. Zubair explained the evolutionof TSH assay generations and discussed their functional and analytical sensitivities. Dr. Mahmoodafrom Sabsazar (Lahore) Campus, IHHN spoke on “Issues in Thyroid Hormone Testing”, including effectof various interferences in immunoassays. This was followed by some interesting case discussions
by Chemical Pathology trainees on Grave’s Disease, Hashimoto’s Thyroiditis, Non-Thyroidal Illness
and T3 thyrotoxicosis. The session was concluded after a post-test and response to queries from theparticipants.

Dr. Adnan Mustafa Zubairi delivering his talk on “Using
Diagnostic Tools Effectively in Thyroid Disease”

29

AACC Has Become ADLM
At their annual meeting in July, AACC announced a name change to the Association for Diagnostics& Laboratory Medicine (ADLM). The move to rename the association was the result of a thoughtful,deliberate process led by the organization’s board of directors. Although the new name makes abold statement, it does not represent a change of direction. Instead, it more accurately reflects
the association’s diverse membership, which includes all professionals working within or adjacentto the clinical lab. Clinical chemistry is still vital to their offerings, and ADLM will remain the proud
professional home for clinical chemists.
Over its 75-year history, AACC embraced every evolution in the field, and that continues as theassociation grows to meet the future. ADLM will continue to advance lab professionals whose
expertise leads to better health for all.
In short, the association is deepening its commitment to better health through laboratory medicine
by broadening its invitation to collaborate.

30

News from the IFCC Website

IFCC complimentary Live Webinar 13th September 2023
Laboratory medicine – a critical role for patients in disease diagnosis and monitoring
REGISTER HERE

Dear Colleagues,
The next IFCC webinar: “Laboratory medicine - a critical role for patients in disease diagnosis andmonitoring” will be held on September 13, 2023.
The laboratory tests evaluate the clinical status, confirm the diagnosis, and allow medical doctors
to assess whether or not the treatment is efficient. Also, laboratory medicine gives the possibility toevaluate the patient and choose which is the best method or methods of personalized diagnosis forthe patient, being integral to prevention, screening, diagnosis, treatment, and monitoring.
This webinar comprises of three following presentations of 20 min each followed by 20 min of panel
discussion at the end.
Chair: Dr. Mirela Ahmadi
Talk 1 - “Assessing the specific tumoral markers, inflammatory status, and vitamin D metabolism
before and after the first chemotherapy cycle for lung cancer patients” - Ms. Andreea Crintea
Talk 2 - “The importance of molecular diagnosis of tuberculosis” - Dr. Mirela Ahmadi
Talk 3 - “The association between the PLIN1 rs2304795 gene and Metabolic Syndrome in obese
patients” Ms. Stanislav Alexandra Alina

Article continued on the next page31

News from the IFCC Website•••

Time Zones: Live presentations starting at: 9:00AM EDT-New York ; 3:00PM CET-Rome; 9:00PM
CST-Beijing;
Important: Please ensure that you carefully determine the time that the presentation will start inyour global time zone. Click here to convert to your time-zone.
Recorded webinar: available on demand
Certificate of participation: available for all registrants

32

IFCC’s Calendar of Congresses,
Conferences & Events
IFCC and Regional Federation
Events
Date

Title

Place

Sep 13,
2023

Laboratory medicine – a criticalrole for patients in diseasediagnosis and monitoringLive
webinarDec 4,- Dec 52023

2023 JCTLM Workshop on: ‘EQA
schemes elucidating the clinicalsuitability of laboratory results’Sèvres,FR

Jan 25, - Jan 26
2024

AFCC CONGRESS 2024

Cairo,EG

May 25,2024

XVII ICPLM - INTERNATIONALCONGRESS OF PEDIATRICLABORATORY MEDICINE

Dubai,UAE

May 26 - Jun 30,
2024

XXVI IFCC WORLDLAB Dubai 2024

Dubai,UAE

May 26, - Jun 30
2024

AFCB Congress in conjunction
with the XXVI IFCC WorldLab
Dubai 2024 Congress

Dubai,UAE

Oct 3 - 6,
2024

XXVI COLABIOCLI 2024

Cartagena,
CO

October 31 Nov 3, 2024

APFCB 2024 Sydney

Sidney,AU

May 18 - 22,
2025

XXVI IFCC-EFLM
EUROMEDLAB 2025

Brussels,
BE

Article continued on the next page33

Corporate Member Events with
IFCC Auspices
Date

Title

Place

Sep 16,2023

Inter-QC Topics

Quality
Academics,
Ciudad deMéxico, MX

Sep 16,2023

International Symposium on
Laboratory Medicine

Snibe,
Negombo, LK

Nov 18,2023

Inter-QC Topics

Quality
Academics,
online, MX

Other events with
IFCC auspices
Click here34

Published ten times a year:

Advertise in
IFCC eNews!
Showcase your products and initiatives
to more than 49.000 laboratory medicine
specialists throughout Europe, North
America, Asia- Pacific, Middle East, Africa
and Latin America: laboratory directors,
clinical chemists, and other clinicallaboratory specialists and technologists,
leading manufacturers, distributors anddealers in the field.
• Ten issues per year
• Free-of-charge to readers• Interactive digital edition

No 1/2
No3
No 4
No5
No 6
No 7/8
No9
No 10
No 11
No 12

January/February
March
April
May
June
July/August
September
OctoberNovember
December

For prices, formats and any further information
on how your company can gain unique access\tointernational markets through advertsingwith IFCC, please email us at enews@ifcc.org.
IFCC Corporate Members receive a 25%
discount on current prices.

35

IFCC Executive Board 2021 - 2023

Khosrow
ADELI
President

TomrisOZBEN
President-electDavid
KINNIBURGH
SecretaryAlexander
HALIASSOS
Treasurer

JosephPASSARELLI
Corporate
Representative

E. HOYARANDA
Asia-Pacific Fed
for Clin Biochem
and Lab Med(APFCB)

A. M. ŠIMUNDIĆ
European Fed ofClin Chem andLab Medicine(EFLM)

A.M. LENA
Latin-American
Confederationof Clin
Biochemistry(COLABIOCLI)T. PILLAY (ZA)
Communications
andPublications
Division Chair

S. BERNARDINI (IT)
Emerging
Technologies
Division Chair

P. LAITINEN (FI)Congresses andConferences
Committee Chair

Regional Representatives

AB OKESINA
AfricanFederation ofClinical Chemistry(AFCC)

A. HEDHILI
Arab
Federation ofClinical Biology(AFCB)

E. DUNN
North American
Fed of Clin
Chem and Lab
Med(NAFCC)IFCC Divisions and C-CC Chairs

C. COBBAERT (NL)
Scientific
Division Chair

N. RIFAI (US)
Education andManagement
Division Chair

IFCC Office Staff(L-R) Elisa Fossati, Paola Bramati, Silvia Colli Lanzi,
Silvia Cardinale, Smeralda Skenderaj, Sofia Giardina

36

IFCC Membership
Full members

Albania (AL)
Algeria (DZ)
Argentina (AR)Armenia (AM)Australia and
New Zealand (AU/NZ)
Austria (AT)
Belgium (BE)Bolivia (BO)
Bosnia Herzegovina (BA)
Brazil (BR)
Bulgaria (BG)
Canada (CA)Chile (CL)
China (Beijing) (CN)China (Taipei) (TW)
Colombia (CO)Croatia (HR)Cuba (CU)
Cyprus (CY)
Czech Republic (CZ)
Denmark (DK)
Dominican Republic (DO)
Ecuador (EC)Egypt (EG)Estonia (EE)
Ethiopia (ET)Finland (FI)France (FR)Georgia (GE)Germany (DE)Greece (GR)
Guatemala (GT)Hong Kong (HK)
Hungary (HU)
Iceland (IS)India (IN)Indonesia (ID)
Iran (IR)Iraq (IQ)
Ireland (IE)
Israel (IL)
Italy (IT)Japan (JP)Jordan (JO)
Kazakhstan (KZ)
Kenya (KE)
Korea (KR)Kosovo (XK)Corporate members

Latvia (LV)
Lebanon (LB)
Libya (LY)
Lithuania (LT)
Luxembourg (LU)
Malawi (MW)Malaysia (MY)Mexico (MX)Montenegro (ME)
Morocco (MA)
Myanmar (MM)
Nepal (NP)
Netherlands (NL)
Nigeria (NG)North Macedonia (MK)Norway (NO)Pakistan (PK)Palestine (PS)Panama (PA)Paraguay (PY)
Peru (PE)Philippines (PH)Poland (PL)Portugal (PT)
Romania (RO)Russia (RU)
Saudi Arabia (SA)Serbia (SRB)
Singapore (SG)Slovak Republic (SK)Slovenia (SI)South Africa (ZA)
Spain (ES)Sri Lanka (LK)
Sudan (SD)
Sweden (SE)Switzerland (CH)
Syrian Arab Republic (SY)
Thailand (TH)Tunisia (TN)Türkiye (TR)Ukraine (UA)United Kingdom (UK)
United States (US)Uruguay (UY)
Vietnam (VN)
Zambia (ZM)
Zimbabwe (ZW)

Regional Federations

Arab Federation of Clinical Biology (AFCB)
African Federation of Clinical Chemistry (AFCC)
Asia-Pacific Federation for Clinical Biochemistry
and Laboratory Medicine (APFCB)
European Federation of Clinical Chemistry
and Laboratory Medicine (EFLM)
Latin America Confederationof Clinical Biochemistry (COLABIOCLI)North American Federation of Clinical Chemistry
and Laboratory Medicine (NAFCC)

AbbottAgappe Diagnostics, Ltd.
Arkray, Inc.
Asahi Kasei Pharma Corp.
Autobio Diagnostics Co., Ltd.
BD Life Sciences –Preanalytical Systems
Beckman Coulter, Inc.
The Binding Site Group, Ltd.
Biomasterclin Laboratorios
Venezuela
Bio-Rad Laboratories
C.P.M. Diagnostic Research
Diagnostica Stago
DiaSorin
DiaSys Diagnostic Systems
GmbH
ET Healthcare Inc.
Fujifilm Wako Pure Chemical
Corporation
Fujirebio Europe
Gentian, AS
Helena Biosciencies Europe
Hemas Hospitals (PVT) Ltd.
HyTest, Ltd. i-SENS, Inc.
Immunodiagnostic Systems- IDS
Instrumentation Laboratory
Jangsu BioPerfectus Co., Ltd.
Labor Team
LumiraDx
Maccura Biotechnology Co.,Ltd.
MedicalSystem Biotechnology
Co., Ltd.

Medix Biochemica
A. Menarini Diagnostics
Mindray - Shenzhen Mindray
Bio-Medical
Nittobo Medical Co., LTD.
Biomedical Corporation
Oneworld Accuracy
Collaboration
PerkinElmer
PHC Europe B.V.
Quality Academics S.C.
QuidelOrtho
Radiometer Medical ApS
Randox Laboratories, Ltd.
Roche Diagnostics
Sansure Biotech Inc.
Sebia S.A.
Sentinel CH SpA
Shanghai Kehua BioEngineering Co., Ltd. Co., Ltd.
Shenzhen YHLO Biotech Co.,Ltd
Siemens Healthcare
Diagnostics
Snibe Co., Ltd.
Synlab
Sysmex Europe, GmbHTechnogenetics
Thermo Fisher ScientificTosoh Corporation United
Robotics Group GmbH
Labor Dr. Wispling hoff
Wuhan Life Origin Biotech
Joint Stock Co., Ltd.

Affiliate Members

Botswana: Institute of Clinical Laboratory Professionals
Brazil: Sociedade Brasileira de Patologia Clínica / Medicina
Laboratorial (SBPC/ML)
China: Lab Medicine Committee, China Association of Medical
Equipment (LMC)
Egypt: Egyptian Association of Healthcare Quality and Patient
SafetyFrance: French National Network of Accredited Laboratories ofMedical Biology (LABAC)
India: Association of Medical Biochemists of India (AMBI)
Iran: Iranian Association of Clinical Laboratory Doctors (IACLD)
Jordan: Society for Medical Technology & Laboratories (SMTL)
Kazakhstan: Public Association - Federation of Laboratory
Medicine (FLM)
Mexico: Federación Nacional de Químicos Clínicos (CONAQUIC
A.C.)
Mexico: Colegio Nacional de Químicos Clínicos en Medicina deLaboratorio (CONQUILAB)
Mexico: Federación Nacional de Colegios Profesionales de laQuímica Clínica, A.C. (FENACQC)
Nepal: Nepalese Association for Clinical Chemistry (NACC)
Philippines: Philippine Council for Quality Assurance in ClinicalLaboratories (PCQACL)
Romania: Order of the Biochemists, Biologists, Chemists in
Romanian Health System (OBBCSSR) Serbia: Serbian Society for
Clinical Laboratory Medicine and Science (SCLM)
Spain: Andalusian Society for Clinical Analysis and Laboratory
Medicine (SANAC)
Spain: Asociación Española de Biopatología Médica - Medicinade Laboratorio (AEBM-ML)
Spain: Asociación Española de Farmacéuticos Analistas (AEFA)
Sri Lanka: College of Chemical Pathologists of Sri Lanka (CCPSL)
Türkiye: Society of Clinical Biochemistry Specialists (KBUD)
Ukraine: Association for Quality Assurance of Laboratory
Medicine (AQALM)
United Arab Emirates: Genetic Diseases Association (UAEGDA)

37

enewsPublisher
Communications and Publications Division(CPD) of the IFCCThe Communications and Publications
Division publishes ten editions of the e-Newsper year, including two double issues.
EditorKatherina Psarra, MSc, PhD
Department of Immunology Histocompatibility Evangelismos Hospital,
Athens, Greece
E-mail: enews@ifcc.org
The eNews is distributed to all IFCC
members registered on-line to receive it andto all IFCC sponsors.
Deadlines for submissions to the eNews
N° 1/2 – January/February: by mid January
N° 3 – March: by mid February
N° 4 – April: by mid March
N° 5 – May: by mid April
N° 6 – June: by mid May
N° 7/8 – July/August: by mid June
N° 9 – September: by mid August
N° 10 – October: by mid September
N° 11 – November: by mid October
N° 12 – December: by mid November
If you want to submit an article oradvertisement to be published in the eNews,
send it to: Katherina Psarra, Editor, IFCC
eNews
E-mail: enews@ifcc.org

Copyright © 2023 IFCC. All rights reserved.
Contents may not be reproduced without
the prior permission of the Communications
and Publications Division (CPD) of the IFCC.

38